Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service sleep apnea & airway implants cases in California: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 15% on average (12 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 0 | 66 | 48% |
| 2020 | 0 | 55 | 50% |
| 2021 | 3 | 54 | 52% |
| 2022 | 4 | 186 | 53% |
| 2023 | 8 | 312 | 55% |
| 2024 | 8 | 343 | 56% |
| 2025 from claims | – | 258 208–302 | 56% |
| 2026 forecast | – | 284 223–357 | 56% |
| 2027 forecast | – | 312 231–412 | 56% |
| 2028 forecast | – | 342 242–472 | 56% |
| 2029 forecast | – | 375 255–538 | 57% |
| 2030 forecast | – | 411 269–610 | 57% |
Hypoglossal nerve stimulation and upper airway procedures. Professional codes (what the surgeon bills): CPT 64582, 64583, 64584, 42145, 41530.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in California; 6 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 6% inpatient hospital, 83% hospital outpatient, 11% surgery center. The share outside the hospital has moved −11 pts since 2023.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 131 | 15,296−0.9%/yr | −0.9%/yr | 4.61.0× | 88% | 19,700 in 2030+4.3%/yr |
| Ear tubes & middle ear surgery | 3 | 633−0.6%/yr | −0.6%/yr | 0.20.8× | 58% | 510 in 2030−3.5%/yr |
| Cochlear implants | 14 | 436+11%/yr | +11%/yr | 0.10.6× | 28% | 770 in 2030+9.8%/yr |
Sleep apnea & airway implants in every state, and its device makers · Every procedure market in California · Every state · Compare with Arizona
Inspire Medical Systems leads with 51% of company spending on these surgeons in 2025, −6 pts on 2024.
In 2025, 11 companies reported engagement with California’s surgeons worth $700K in consulting, speaking, meals and travel tied to these products, about $88K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 18 clearances and approvals in the category, 2 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.